BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33891858)

  • 1. Thoracic and Extrathoracic Malignancies in Lung Cancer Screening Patients With Histories of Malignancy.
    Byrne SC; Hammer MM
    J Am Coll Radiol; 2021 Aug; 18(8):1077-1083. PubMed ID: 33891858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Extrapulmonary Malignancy During Lung Cancer Screening: 5-Year Analysis at a Tertiary Hospital.
    Chintanapakdee W; Mendoza DP; Zhang EW; Botwin A; Gilman MD; Gainor JF; Shepard JO; Digumarthy SR
    J Am Coll Radiol; 2020 Dec; 17(12):1609-1620. PubMed ID: 33058791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Diagnostic CT and Patient Retention in a Lung Cancer Screening Program.
    Byrne SC; Hammer MM
    J Am Coll Radiol; 2022 Jan; 19(1 Pt A):47-52. PubMed ID: 34752759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?
    O'Dwyer E; Halpenny DF; Ginsberg MS
    Eur Radiol; 2021 Jan; 31(1):458-467. PubMed ID: 32728771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 6. Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial.
    Nguyen XV; Davies L; Eastwood JD; Hoang JK
    J Am Coll Radiol; 2017 Mar; 14(3):324-330. PubMed ID: 28259326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
    White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
    Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the 30-Pack-Year Smoking Threshold in African Americans From an Underserved Lung Cancer Screening Program.
    Basu A; Kopulos L; Geissen N; Sukhal S; Smith SB
    J Am Coll Radiol; 2021 Jan; 18(1 Pt A):27-33. PubMed ID: 32946802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting.
    Bastani M; Patel D; Silvestri GA; Raoof S; Chusid J; Cohen SL
    J Am Coll Radiol; 2022 Feb; 19(2 Pt A):232-239. PubMed ID: 34861204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey.
    López DB; Flores EJ; Miles RC; Wang GX; Glover M; Shepard JO; Lehman CD; Narayan AK
    J Am Coll Radiol; 2019 Oct; 16(10):1433-1439. PubMed ID: 31092347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care.
    Tailor TD; Bell S; Fendrick AM; Carlos RC
    J Am Coll Radiol; 2022 Jan; 19(1 Pt A):35-46. PubMed ID: 34600897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies.
    Brock MV; Alberg AJ; Hooker CM; Kammer AL; Xu L; Roig CM; Yang SC
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1119-25. PubMed ID: 15052211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endobronchial ultrasonography for mediastinal lymphadenopathy in cases with extrathoracic malignancy.
    Tertemiz KC; Alpaydin AO; Karacam V
    Surg Endosc; 2017 Jul; 31(7):2829-2836. PubMed ID: 27770251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with a Previous History of Malignancy Undergoing Lung Cancer Screening: Clinical Characteristics and Radiologic Findings.
    Halpenny DF; Cunningham JD; Long NM; Sosa RE; Ginsberg MS
    J Thorac Oncol; 2016 Sep; 11(9):1447-52. PubMed ID: 27223458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Su CT; Bhargava A; Shah CD; Halmos B; Gucalp RA; Packer SH; Ohri N; Haramati LB; Perez-Soler R; Cheng H
    Clin Lung Cancer; 2018 Sep; 19(5):e767-e773. PubMed ID: 29937386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
    Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
    Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-Discordant Lung Cancer Screening: Emerging Demand and Provided Indications.
    Wang GX; Neil JM; Fintelmann FJ; Little BP; Narayan AK; Flores EJ
    J Am Coll Radiol; 2021 Mar; 18(3 Pt A):395-405. PubMed ID: 32905787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.